AIMS: Idiopathic left ventricular hypertrophy (LVH) is defined as LVH in the absence of myocyte disarray or secondary causes. It is unclear whether idiopathic LVH represents the phenotypic spectrum of hypertrophic cardiomyopathy (HCM) or whether it is a unique disease entity. We aimed to ascertain the prevalence of HCM in first-degree relatives of decedents from sudden death with idiopathic LVH at autopsy. Decedents also underwent molecular autopsy to identify the presence of pathogenic variants in genes implicated in HCM. METHODS AND RESULTS: Families of 46 decedents with idiopathic LVH (125 first-degree relatives) were investigated with electrocardiogram, echocardiogram exercise tolerance test, cardiovascular magnetic resonance imaging, 24-h Holter, and ajmaline provocation test. Next-generation sequencing molecular autopsy was performed in 14 (30%) cases. Decedents with idiopathic LVH were aged 33 ± 14 years and 40 (87%) were male. Fourteen families (30%) comprising 16 individuals were diagnosed with cardiac disease, including Brugada syndrome (n = 8), long QT syndrome (n = 3), cardiomyopathy (n = 2), and Wolff-Parkinson-White syndrome (n = 1). None of the family members were diagnosed with HCM. Molecular autopsy did not identify any pathogenic or likely pathogenic variants in genes encoding sarcomeric proteins. Two decedents had pathogenic variants associated with long QT syndrome, which were confirmed in relatives with the clinical phenotype. One decedent had a pathogenic variant associated with Danon disease in the absence of any histopathological findings of the condition or clinical phenotype in the family. CONCLUSION: Idiopathic LVH appears to be a distinct disease entity from HCM and is associated with fatal arrhythmias in individuals with primary arrhythmia syndromes. Family screening in relatives of decedents with idiopathic LVH should be comprehensive and encompass the broader spectrum of inherited cardiac conditions, including channelopathies. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Idiopathic left ventricular hypertrophy (LVH) is defined as LVH in the absence of myocyte disarray or secondary causes. It is unclear whether idiopathic LVH represents the phenotypic spectrum of hypertrophic cardiomyopathy (HCM) or whether it is a unique disease entity. We aimed to ascertain the prevalence of HCM in first-degree relatives of decedents from sudden death with idiopathic LVH at autopsy. Decedents also underwent molecular autopsy to identify the presence of pathogenic variants in genes implicated in HCM. METHODS AND RESULTS: Families of 46 decedents with idiopathic LVH (125 first-degree relatives) were investigated with electrocardiogram, echocardiogram exercise tolerance test, cardiovascular magnetic resonance imaging, 24-h Holter, and ajmaline provocation test. Next-generation sequencing molecular autopsy was performed in 14 (30%) cases. Decedents with idiopathic LVH were aged 33 ± 14 years and 40 (87%) were male. Fourteen families (30%) comprising 16 individuals were diagnosed with cardiac disease, including Brugada syndrome (n = 8), long QT syndrome (n = 3), cardiomyopathy (n = 2), and Wolff-Parkinson-White syndrome (n = 1). None of the family members were diagnosed with HCM. Molecular autopsy did not identify any pathogenic or likely pathogenic variants in genes encoding sarcomeric proteins. Two decedents had pathogenic variants associated with long QT syndrome, which were confirmed in relatives with the clinical phenotype. One decedent had a pathogenic variant associated with Danon disease in the absence of any histopathological findings of the condition or clinical phenotype in the family. CONCLUSION:Idiopathic LVH appears to be a distinct disease entity from HCM and is associated with fatal arrhythmias in individuals with primary arrhythmia syndromes. Family screening in relatives of decedents with idiopathic LVH should be comprehensive and encompass the broader spectrum of inherited cardiac conditions, including channelopathies. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: David J Tester; Argelia Medeiros-Domingo; Melissa L Will; Carla M Haglund; Michael J Ackerman Journal: Mayo Clin Proc Date: 2012-06 Impact factor: 7.616
Authors: Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba Journal: Circulation Date: 2010-02-19 Impact factor: 29.690
Authors: Richard D Bagnall; Robert G Weintraub; Jodie Ingles; Johan Duflou; Laura Yeates; Lien Lam; Andrew M Davis; Tina Thompson; Vanessa Connell; Jennie Wallace; Charles Naylor; Jackie Crawford; Donald R Love; Lavinia Hallam; Jodi White; Christopher Lawrence; Matthew Lynch; Natalie Morgan; Paul James; Desirée du Sart; Rajesh Puranik; Neil Langlois; Jitendra Vohra; Ingrid Winship; John Atherton; Julie McGaughran; Jonathan R Skinner; Christopher Semsarian Journal: N Engl J Med Date: 2016-06-23 Impact factor: 91.245
Authors: Mathilde R Rivaud; John A Jansen; Pieter G Postema; Eline A Nannenberg; Yuka Mizusawa; Roel van der Nagel; Rianne Wolswinkel; Ingeborg van der Made; Gerard A Marchal; Sridharan Rajamani; Luiz Belardinelli; J Peter van Tintelen; Michael W T Tanck; Allard C van der Wal; Jacques M T de Bakker; Harold V van Rijen; Esther E Creemers; Arthur A M Wilde; Maarten P van den Berg; Toon A B van Veen; Connie R Bezzina; Carol Ann Remme Journal: Eur Heart J Date: 2018-08-14 Impact factor: 29.983
Authors: Chee Jian Pua; Jaydutt Bhalshankar; Kui Miao; Roddy Walsh; Shibu John; Shi Qi Lim; Kingsley Chow; Rachel Buchan; Bee Yong Soh; Pei Min Lio; Jaclyn Lim; Sebastian Schafer; Jing Quan Lim; Patrick Tan; Nicola Whiffin; Paul J Barton; James S Ware; Stuart A Cook Journal: J Cardiovasc Transl Res Date: 2016-02-17 Impact factor: 4.132
Authors: Cristina Basso; Beatriz Aguilera; Jytte Banner; Stephan Cohle; Giulia d'Amati; Rosa Henriques de Gouveia; Cira di Gioia; Aurelie Fabre; Patrick J Gallagher; Ornella Leone; Joaquin Lucena; Lubov Mitrofanova; Pilar Molina; Sarah Parsons; Stefania Rizzo; Mary N Sheppard; Maria Paz Suárez Mier; S Kim Suvarna; Gaetano Thiene; Allard van der Wal; Aryan Vink; Katarzyna Michaud Journal: Virchows Arch Date: 2017-09-09 Impact factor: 4.064
Authors: Mercedes Iglesias; Tomas Ripoll-Vera; Consuelo Perez-Luengo; Ana Belen García; Susana Moyano; Juan Carlos Canos; Juan Carlos Borondo; Jorge Alvarez; Damian Heine-Suñer; Bernardino Barcelo Journal: J Clin Med Date: 2021-04-21 Impact factor: 4.241